Anbio Biotechnology (NNNN) Shares Outstanding (2023 - 2025)

Anbio Biotechnology has reported Shares Outstanding (Entity) for 3 years, with the latest figure at $143.9 million in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 1.12% year-over-year to $143.9 million in Q4 2025; TTM through Dec 2025 was $143.9 million, a 1.12% increase from a year earlier, with the FY2025 full-year figure at $143.9 million, up 1.12% from the prior year.
• Shares Outstanding (Entity) was $143.9 million for Q4 2025 at Anbio Biotechnology, up from $142.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $143.9 million in Q4 2025, with the low at $142.3 million in Q4 2023.
• Average Shares Outstanding (Entity) over 3 years is $142.8 million, with a median of $142.3 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) changed 0.0% in 2024, then grew 1.12% in 2025.
• Over 3 years, Shares Outstanding (Entity) stood at $142.3 million in 2023, then changed by 0.0% to $142.3 million in 2024, then rose by 1.12% to $143.9 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $143.9 million (Q4 2025), $142.3 million (Q4 2024), and $142.3 million (Q4 2023), per Business Quant data.